Home › Research › Topics › gsk-3
gsk-3
2 studies tagged gsk-3, dated 2016-10-01 to 2022-01-01. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
Studies
2 studies carry this tag.
Date range
2016 to 2022
Top journals
- Journal of Alzheimer's disease : JAD 2
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
These proteins can serve as potential blood markers for the diagnosis of AD and EO can suppress their level.
-
Glycogen synthase kinase (GSK)-3β is a multifunctional protein that has been implicated in the pathological characteristics of Alzheimer's disease (AD), including the heightened levels of neurofibrillary tangles, amyloid-beta (Aβ), and neurodegeneration.